The challenges facing pharmaceutical industry in preserving the planet
The pharmaceutical world needs to protect patients while reducing its environmental impact. The emergence of new pathologies of global impact expands needs for optimal design of drugs and medical devices. Similar challenges exist for the agrochemical sector.
Reducing the environmental impact of products
To industrials, it is now a priority to include the environmental footprint reduction at the design stage, during the manufacturing process and all the way to the end of the lifecycle of all equipment. New regulatory rules raised the development costs for both agrochemicals and pharmaceuticals sharply. The increase in the global population has already led to an intensification of crop production and a higher demand on drugs and this will continue in order to secure world food supply and health without negative impact on the environment.
Boosting profitability with innovative solutions
With the advent of generic medicines, with heavy pressure from governments regarding the price of drugs and with cuts in the amounts refunded, industrials have strong incentives to produce the same treatments at a lower cost. This includes also the production of medical devices of high efficiency and low cost. Another example is embracing circular economy through turning used solvents into a secondary raw material of similar quality, hence improving overall profitability.
Scaling down investments for infrastructures that are not core business
Given the annual 4.4% market growth until 2020 and €149.8b in R&D expenditures for 2015, industry is already investing in the future by increasing its production capacity and developing the factory of the future. Nowadays, because of a constant changing environment, it is necessary to take another look at how financial resources are being allocated. Possessing an asset is no longer the benchmark, as industrials may rent, share and outsource their infrastructure.
SCIENOMICS is a software company specialized in materials modeling and simulations. We support our customers’ decision-making process in materials innovation and address related critical business issues through our software technology & contract research services we offer. This will enable our customers to
- improve performances and profitability
- reduce operational costs and risks
- optimize the product design process
- support innovative R&D activities
- help to identify sustainable development processes
- focus the research and development activity
Our range of offers concentrates on the needs of both pharmaceutical development and delivery systems as well as plant protection products, where the development challenges are similar to those in pharmaceuticals.
Product development, where SCIENOMICS technology helps identifying new delivery systems, predicts the stability of formulations, estimates the solubility of drugs in a variety of solvents and allows control of growth mechanisms of crystalline materials. For agrochemicals, similar issues exist, an additional one is the development of compounds with low water solubility but highly soil‐adsorptive. The challenges of drug and agrochemical development after the initial discovery phase can be met with various technologies all included in SCIENOMICS MAPS platform.
Medical devices are of increasing importance in times, when new pathologies of global impact are requiring innovative solutions, and the interaction of biological compounds with artificial polymers or inorganic materials for example in surgical masks, respirators or body implants are contributing significantly for the improvement of human or animal health. MAPS offers tools for solving these complex problems on all levels of modeling scales.
